Financhill
Back

Direxion Daily S&P Biotech Bull 3X Shares Vs. Aligos Therapeutics Industry Stock Comparison

Sell
6

LABU
Direxion Daily S&P Biotech Bull 3X Shares

Last Price:
$94.88
Seasonality Move:
-9.57%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$39.75
Seasonality Move:
7.18%
Sell
6
Direxion Daily S&P Biotech Bull 3X Shares (LABU) is a Sell

Is Direxion Daily S&P Biotech Bull 3X Shares a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bull 3X Shares [LABU] share price is $89.79. The Score for LABU is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • LABU is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $38.35. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LABU Stock Price Chart

What is Direxion Daily S&P Biotech Bull 3X Shares's stock price today?

  • The Direxion Daily S&P Biotech Bull 3X Shares share price today is $89.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABU is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $38.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

LABU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.71 Sell
Relative Strength Index (14 RSI): 31.07 Sell
Chaikin Money Flow: 581295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.31 - 122.15) Sell
Bollinger Bands (100): (113.17 - 136.65) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.1 Buy
Relative Strength Index (14 RSI): 79.33 Buy
Chaikin Money Flow: 265554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.3 - 32.5) Buy
Bollinger Bands (100): (7.16 - 22.66) Buy

LABU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.86 Sell
20-day SMA: 113.34 Sell
50-day SMA: 120.35 Sell
200-day SMA: 120.63 Sell
8-day EMA: 102.06 Sell
20-day EMA: 110.28 Sell
50-day EMA: 117.6 Sell
200-day EMA: 120.87 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34 Buy
20-day SMA: 28.23 Buy
50-day SMA: 17.95 Buy
200-day SMA: 16.14 Buy
8-day EMA: 33.62 Buy
20-day EMA: 28.8 Buy
50-day EMA: 21.66 Buy
200-day EMA: 17.2 Buy

Direxion Daily S&P Biotech Bull 3X Shares Earnings Growth & LABU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Direxion Daily S&P Biotech Bull 3X Shares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):